|
Safety and Efficacy of MK-8669 (Ridaforolimus) + MK-2206 (AKT Inhibitor) in Patients with Advanced Breast Cancer with PI3K Pathway Dependence |
|
|
|
Titel: |
Safety and Efficacy of MK-8669 (Ridaforolimus) + MK-2206 (AKT Inhibitor) in Patients with Advanced Breast Cancer with PI3K Pathway Dependence |
Auteur: |
Gupta, S. Munster, P. Hollebecque, A. Argiles, G. Guren, T. Cheng, J. Wang, R. Swift, A. Tosolini, A. Piha-Paul, S. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 25 () nr. S1 pagina's i25 |
Jaar: |
2014 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|